Understanding Downbeat and upbeat nystagmus
In downbeat nystagmus the eyes drift upward and make a faster downward correction; upbeat has a downward drift and upward correction. Those names describe the observed eyes, not a rule that the perceived world moves in the same direction. Both may cause oscillopsia, blur and difficulty with stable fixation. [1] [2] [3]
The two patterns are grouped here for comparison rather than treated as one disease. They can arise from different central vestibular or gaze-control disturbances, and their course can differ. Head position, gaze and associated neurological signs help interpret what is happening. [1] [2] [3]
One condition. Different experiences.
Explore different selected symptom features, then read how they may vary. These examples are not stages or a clinical test.
Original VisualSim schematic illustrations, informed by the cited clinical descriptions. These are not study figures, patient recordings or validated severity levels.
Vertical movement or blur
A stationary scene may seem to bounce or drift, and small targets can be difficult to hold. Not everyone describes a clean up-and-down movement, particularly when other ocular findings coexist. [2] [3]
Different in useful gaze positions
Downbeat symptoms often change in side gaze or downgaze. Upbeat patterns also vary with gaze and position, but not in one universal way; reading or head posture should be assessed individually. [2] [6]
Balance and neurological burden
Dizziness or ataxia can accompany the eye movements and may need separate rehabilitation. A smaller eye oscillation does not by itself establish improved walking or daily safety. [2] [4]
Name the fast phase, investigate the cause
Original waveform concept, not an eye recording or a prediction of perceived world motion. [1] [2] [3]
Original VisualSim teaching diagram · © VisualSim. Clinical basis in linked sources; not a published study figure. Image provenance.- Slow drift
The eyes drift away from stable fixation.
- Fast reset
A downward reset is called downbeat and an upward reset upbeat.
- Interpret the context
Gaze, position, neurological findings and selected tests distinguish different causes.
What is happening—and what remains uncertain
Brainstem and cerebellar networks balance vertical vestibular signals and hold gaze. A disturbance can create a slow drift away from the target, followed by a rapid reset. The exact pathway differs across causes, so a shared direction is not a diagnosis of one lesion. [1] [2] [3]
Downbeat can accompany cerebellar degeneration, craniocervical structural disease, medication or metabolic problems and genetic disorders. FGF14 repeat-expansion disease is a more recently recognized explanation in selected previously unexplained cases. Upbeat is often associated with brainstem lesions or nutritional and other neurological disorders; neither list is exhaustive. [2] [3] [5] [7]
What can look similar?
Pendular versus jerk
Pendular nystagmus has smoother back-and-forth oscillations without the same drift/reset waveform. Its symptom-treatment evidence should not be transferred automatically to vertical jerk patterns. [1]
Similar-looking symptoms can have different causes. A matching picture cannot establish a diagnosis.
What an assessment may involve
- Characterize the movementThe examiner observes slow and fast phases, gaze and positional effects, fixation, alignment and associated nystagmus. Video-oculography can quantify selected features. [1] [6]
- Review causes and exposuresHistory includes onset, neurological symptoms, medication changes, nutritional risk, prior disease and family history. Imaging and selected laboratory tests evaluate plausible central, structural or metabolic explanations. [2] [3]
- Consider targeted genetics when appropriateSpecialist assessment may consider FGF14-related ataxia in a compatible clinical context. Repeat-expansion testing and interpretation differ from ordinary sequence panels; a negative generic test does not answer every genetic question. [7]
What may help—and what is still being studied
Treat a relevant underlying cause
A correctable nutritional, medication-related or structural problem needs its own management. Medication changes and urgent deficiency treatment belong with the treating team, not a simulator-based decision. [2] [3]
Discuss specialist symptom medication
A small placebo-controlled downbeat trial supports selected eye-movement and acuity effects of 4-aminopyridine. Safety, contraindications, formulation and local licensing require specialist review; this is not evidence for self-treatment or equal benefit in upbeat disease. [4]
What this can mean for daily life
Find a workable reading setup
Discuss document and screen position with an orthoptist rather than assuming a fixed chin or gaze posture helps everyone. Report any associated neck discomfort. [8]
Record when instability occurs
Note whether the scene moves at rest, during head movement or in a particular gaze. Include duration and accompanying dizziness or other symptoms. [1] [8]
Review treatment in real tasks
Report clarity, reading time, walking and side effects together. Improvement on an eye recording or a near chart may not match the activity that matters most. [4]
Bring a clearer description to your appointment
Choose the questions you want to discuss. These choices stay in this page’s memory.
Research, with the context left in
Selected studies and guidance, with their populations and limitations. These are curated educational summaries, not a complete systematic review or a formal evidence rating.
Randomized double-blind crossover trial of 4-aminopyridine for downbeat nystagmus
Reduced slow-phase velocity and improved near acuity and some mobility measures; patient satisfaction did not differ from placebo. [4]
Limits and applicability: Brief treatment periods and a selected downbeat population limit long-term and upbeat generalization. A physiological response is not universal daily-life benefit.
GAA-FGF14 disease in a large downbeat nystagmus cohort
Found large FGF14 expansions frequently in this selected cohort, with preliminary treatment-response associations. [5]
Limits and applicability: Not prevalence among all downbeat cases. Drug-response analyses were mostly observational; four-person placebo-controlled eye-recording data reused an earlier trial, not an independent new trial. Intermediate-repeat interpretation remains nuanced.
Upbeat nystagmus: clinicoanatomical correlations in 15 patients
Documented different brainstem lesion locations, gaze/position effects and changing patterns during acute illness. [6]
Limits and applicability: Small selected historical series; frequent transient improvement cannot guarantee resolution in other causes.
Questions researchers still need to answer
- Which downbeat subgroups obtain durable functional benefit from symptom medication?
- What are the penetrance, testing and outcome implications of intermediate FGF14 repeat sizes in diverse populations?
- Which treatments improve persistent upbeat symptoms beyond spontaneous recovery of the underlying illness?
Trusted places to go next
Selected clinical references, research, practical support and ways to connect. Official pages checked 24 October 2026; each entry explains its scope and region.
Nystagmus Network
Information, education support and separate online connection routes for acquired nystagmus, adults with congenital nystagmus and families. Peer experience is not medical advice.
Connections listed by the organization.
National Ataxia Foundation support groups
Relevant when nystagmus is part of an established ataxia disorder. Official group and meeting directory, including virtual options; peer support is not medical advice or a diagnostic service.
Connections listed by the organization.
RNIB community connection and wellbeing
Broader peer connection for people affected by persistent sight difficulties and their families; not a condition-specific group or medical advice. Check each service’s geographic eligibility.
Connections listed by the organization.
GeneReviews: GAA-FGF14-related ataxia
Detailed genetic and clinical explanation for a selected possible cause, not a diagnosis for everyone with downbeat nystagmus.
Questions you may still have
Does downbeat mean the world moves down?
The term names the fast eye movement. Perceived motion depends on the full waveform and visual adaptation and is not a direct copy of that direction. [1]
Are downbeat and upbeat the same disease?
No. They are distinct signs that can have different causes, courses and treatment evidence. [2] [3]
Does a genetic study mean most people have FGF14 disease?
No. The 2024 study selected patients with previously idiopathic downbeat nystagmus. Its frequency is not a population probability. [5]
Can a normal general gene panel exclude every cause?
No. Some repeat expansions require targeted techniques and specialist interpretation; testing must fit the clinical question. [7]
Sources, image credits and review status
Compiled by VisualSim from clinical references and published research. Sources checked 24 October 2026. Independent clinical review has not been recorded; no named clinical reviewer or clinical validation is claimed. Research evidence and its limitations are linked below.
- Bárány Society nystagmus classification consensus (2019; guideline).
Opened definitions of waveform, direction and provoking conditions.
Checked 2026-10-24 · Full text checked - Marcelli and colleagues: Downbeat nystagmus: a clinical and pathophysiological review (2024; review).
Opened original review; genetic and treatment claims checked against original studies and GeneReviews.
Checked 2026-10-24 · Full text checked - Upbeat nystagmus: a clinical and pathophysiological review (2025; review).
Opened original review; case-based treatment suggestions not treated as randomized efficacy.
Checked 2026-10-24 · Full text checked - Claassen and colleagues: Randomized double-blind crossover trial of 4-aminopyridine for downbeat nystagmus (2013; trial).
Opened original abstract; satisfaction and locomotor outcomes distinguished from eye speed.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - GAA-FGF14 disease: defining its frequency, molecular basis and 4-aminopyridine response in a large downbeat nystagmus cohort (2024; observational).
Original indexed abstract checked; selected idiopathic cohort, partial treated denominators and reused four-person controlled data noted.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - Kim and colleagues: Upbeat nystagmus: clinicoanatomical correlations in 15 patients (2006; observational).
Original indexed abstract and discussion checked; not a prognosis guarantee.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - Pellerin and colleagues: GAA-FGF14-Related Ataxia, GeneReviews (2024; review).
Opened current chapter and checked repeat-size penetrance, testing limitations and preliminary treatment scope.
Checked 2026-10-24 · Public page checked - Kamath and colleagues: How should I approach and manage adult-onset oscillopsia? (2024; review).
Original indexed clinical pathways checked; direct publisher access limited.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed
The simulator helps people communicate an experience. It cannot diagnose a condition, measure a visual field, or establish that someone is safe to drive.